Fighting COVID involves a combination of prevention, early treatment, and smart symptom management at home. The most powerful tool if you’re already sick and at higher risk for complications is the antiviral Paxlovid, which reduced hospitalizations and death by 87% in clinical trials. But there’s a wider toolkit worth knowing about, from vaccines and air filtration to the basics of rest and recovery.
Antiviral Treatment Within the First Five Days
If you test positive and are at higher risk for severe illness (due to age, immune conditions, or chronic disease), the most effective step is starting an antiviral medication quickly. Paxlovid is approved for adults and authorized for children 12 and older who weigh at least 88 pounds. It’s a five-day oral course taken twice daily, and it needs to be started within five days of your first symptoms. In trials among unvaccinated people at higher risk, it cut the chance of hospitalization or death by 87%.
A second antiviral, molnupiravir, is also available for adults but has shown low efficacy against severe outcomes in trials, with particularly weak evidence among vaccinated people. It’s generally considered a backup option when Paxlovid isn’t suitable, such as for people who take medications that interact with it or who have severe kidney or liver problems.
The critical takeaway: timing matters enormously. If you’re in a higher-risk group, test early and contact a provider the same day you get a positive result. Waiting until day six or seven can put you outside the treatment window.
Vaccines and Hybrid Immunity
Updated COVID vaccines for the 2024-2025 season target Omicron subvariants (JN.1 and KP.2 strains) and are available from Moderna, Pfizer-BioNTech, and Novavax. For most adults, one dose of the updated vaccine is the current recommendation. Adults 65 and older are recommended to get a second dose six months after their first updated shot, with a minimum interval of two months. People with moderate or severe immune compromise can receive two or more doses of the updated vaccine based on their provider’s guidance.
Vaccination alone provides meaningful but time-limited protection. People who have both prior infection and vaccination, sometimes called hybrid immunity, start with stronger defenses. After a booster dose, hybrid immunity offered about 80% protection, but this dropped to roughly 37% after 16 weeks. Protection against Omicron reinfection specifically fell to about 50% at six months. This doesn’t mean vaccines aren’t worth it. They still substantially reduce the risk of severe illness, hospitalization, and death, even as their ability to prevent any infection fades.
Managing Symptoms at Home
Most people with COVID have mild illness and recover at home. Over-the-counter pain relievers like acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) can help with fever, headache, body aches, and sore throat. Stay hydrated, rest, and monitor your symptoms. There’s no special protocol beyond what you’d do for a bad cold or flu.
Watch for warning signs that suggest things are getting worse: trouble breathing, persistent chest pain or pressure, confusion, or an inability to stay awake. These warrant immediate medical attention regardless of your risk category.
Vitamin D and Zinc: What the Evidence Shows
Vitamin D has gotten significant attention as a COVID fighter, but the evidence is mixed and depends heavily on how and when it’s used. A large randomized trial gave hospitalized COVID patients a single high dose of vitamin D3 and found no benefit: hospital stays, ICU admissions, ventilation rates, and mortality were similar to placebo. On the other hand, a Spanish pilot study found dramatically lower ICU admissions among patients who received a form of vitamin D alongside standard care, with only 1 out of 50 supplemented patients needing intensive care compared to 13 out of 26 in the control group.
The most consistent finding is that preventive supplementation, taken before getting sick, appears to reduce the likelihood of ICU admission if you do get infected, with a pooled analysis showing about a 68% reduction in odds. A Saudi Arabian study found that higher daily vitamin D doses helped resolve cough and taste loss faster, though they didn’t shorten the overall illness. The practical interpretation: if you’re deficient in vitamin D (and many people are), correcting that deficiency is sensible. Megadosing after you’re already seriously ill probably won’t help.
Reducing Exposure Indoors
COVID spreads primarily through the air, which makes the quality of air around you one of the most controllable risk factors. N95 respirators remain far superior to surgical masks. Testing shows that standard surgical masks allow a median inward leakage of about 96%, meaning almost all surrounding air gets through unfiltered. N95 respirators, by contrast, had a median inward leakage of just 0.78%. That’s not a subtle difference. If you’re in a high-risk setting like a crowded waiting room or visiting someone who’s sick, an N95 offers real protection.
Air purifiers with HEPA filters also make a measurable difference. In a study conducted inside a COVID hospital, rooms equipped with HEPA-based air cleaners showed up to a 98.1% reduction in airborne viral particles. Departments using negative-pressure HEPA filtration had zero detectable virus in the air. You don’t need hospital-grade equipment at home, but running a portable HEPA purifier in the room where a sick household member is isolating can meaningfully cut transmission risk.
Returning to Exercise After Infection
One of the most common questions after recovering from COVID is when it’s safe to work out again. The general guideline is to allow two to three days of gradual return for every day of training you missed due to illness. So if you were sick for a week, expect roughly two to three weeks of building back up.
The order matters: increase how often you exercise first, then how long each session lasts, and finally how hard you push. Start with moderate intensity, roughly 50-70% of your maximum effort, and hold that level for four to six weeks before adding higher intensity work. This phased approach is especially important because COVID can affect the heart. In cases where myocarditis (heart inflammation) is suspected or confirmed, competitive sports and intense training should be avoided for at least three to six months, depending on how well heart function recovers.
For most people with mild illness, this level of caution isn’t necessary. But if you experienced chest pain, significant shortness of breath, or heart palpitations during your illness, get cleared by a provider before ramping up physical activity.